Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3151 - 3160 of 3439 results found

Therapie idiopathischer Apnoen, Bradykardien und Hypoxämien bei Früh- und Reifgeborenen. S2k-LL (GNPI, DGKJ)

MeSH Terms
Infant; Premature (M01.060.703.520.520); Infant; Premature; Diseases (C16.614.521)
Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
Therapy of idiopathic apneas, bradycardia and hypoxaemia in premature and mature babies
Date for Review
31/01/2025
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2020

Therapie pathologischer Narben (hypertrophe Narben und Keloide). S2k-LL (DDG)

MeSH Terms
Keloid (C17.300.200.425); Keloid (C23.550.355.274.510); Keloid (A10.165.450.300.425)
Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
Treatment of pathologic scars (hypertrophic scars and keloids)
Date for Review
31/12/2024
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2020

Therapie primärer Antikörpermangelerkrankungen. S3-LL (API)

MeSH Terms

Immunologic Deficiency Syndromes (C20.673)

Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
Treatment of Patients with antibody deficiency syndromes
Date for Review
01/12/2024
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Under Review
Languages
German
Authors
AWMF (DE)
Publication Year
2019

Therapie und Prävention der Adipositas im Kindes- und Jugendalter. S3-LL (DAG, DGKJ)

MeSH Terms

Adiposity (G03.180.134.500); Obesity (C18.654.726.500); Obesity (C23.888.144.699.500); Obesity (E01.370.600.115.100.160.120.699.500); Obesity (G07.100.100.160.120.699.500); Biochemical Phenomena (G02.111)

Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
Therapy and prevention of obesity in childhood and adolescence
Date for Review
30/09/2024
Publication Scope
management
prevention
Countries of Application
Germany
Guideline Publication Status
Under Review
Languages
German
Authors
AWMF (DE)
Publication Year
2019

Therapie von Sprachentwicklungsstörungen. S2k-LL (DGPP)

MeSH Terms
Language Disorders (C10.597.606.150.500); Language Disorders (C23.888.592.604.150.500)
Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
therapy of language development disorders
Keywords
Sprachentwicklungsstörung, Sprachentwicklungsverzögerung, Late Talkers, Aussprachestörung, phonetische Störungen, phonologische Störung, lexikalisch-semantische Störung, morphologisch-syntaktische Störungen, pragmatisch-kommunikative Störungen, Sprachentwicklungsstörung bei Mehrsprachigkeit, Hörstörung, Mehrfachbehinderung, Autismus-Spektrum-Störung, selektiver Mutismus
Date for Review
21/12/2027
Publication Date
22/12/2022
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2022

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

MeSH Terms
carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, ErbB Receptors, HER2, HER-2, HER2-positive, HER2- overexpressing, HER2 gene amplification, Anaplastic Lymphoma Kinase, Receptor Protein-Tyrosine Kinases, Receptor, trkC, Proto-Oncogene Proteins, ROS1, ROS-1, Proto-Oncogene Proteins c-ret, Proto-Oncogene Proteins c-met, Phosphatidylinositol 3-Kinase, Genes, erbB-2, Quinazolines, Piperidines, Aminopyridines, Sulfones, Protein Kinase Inhibitors, Carbazoles, Lactams, Macrocyclic, Imidazoles, Pyrimidines, radiotherapy
Guideline Contact
Emily Vella; pebconc@mcmaster.ca
Keywords
carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, radiotherapy
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Publication Date
2021-02-16
Date of Last Evidence Search
2020-02-04
Methods Applied
Systematic review-based, Externally reviewed; Evidence quality assessment
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
PEBC (Program in evidenced-based care)
Publication Year
2021
Buttons
My Saved Lists